CATTABRIGA, Elena
 Distribuzione geografica
Continente #
NA - Nord America 3.671
AS - Asia 1.778
EU - Europa 1.081
SA - Sud America 214
AF - Africa 27
OC - Oceania 2
Totale 6.773
Nazione #
US - Stati Uniti d'America 3.613
SG - Singapore 690
CN - Cina 600
DE - Germania 314
UA - Ucraina 228
BR - Brasile 184
TR - Turchia 154
HK - Hong Kong 153
GB - Regno Unito 127
VN - Vietnam 84
IT - Italia 72
SE - Svezia 70
FI - Finlandia 69
RU - Federazione Russa 62
FR - Francia 48
CA - Canada 37
IN - India 26
PL - Polonia 24
NL - Olanda 23
JP - Giappone 19
MX - Messico 16
ZA - Sudafrica 16
IQ - Iraq 14
AR - Argentina 12
BD - Bangladesh 12
BE - Belgio 11
LT - Lituania 11
ES - Italia 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
ID - Indonesia 4
AT - Austria 3
CL - Cile 3
CO - Colombia 3
UZ - Uzbekistan 3
AU - Australia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
KR - Corea 2
OM - Oman 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.773
Città #
Singapore 413
Ashburn 330
Woodbridge 329
Fairfield 298
Houston 270
Chandler 259
Jacksonville 241
Ann Arbor 209
Beijing 200
Santa Clara 190
Hong Kong 153
Seattle 125
Wilmington 104
Nanjing 93
Los Angeles 89
Cambridge 87
Dallas 70
Izmir 70
New York 68
Princeton 55
Bremen 46
Munich 43
Boardman 42
Milan 35
Shanghai 32
Dearborn 30
Ho Chi Minh City 29
Addison 25
Falkenstein 25
San Diego 22
São Paulo 22
Frankfurt am Main 20
Nanchang 19
Orem 19
Shenyang 19
Tianjin 19
Hefei 18
Warsaw 18
Buffalo 17
Hanoi 16
Hebei 16
Montreal 16
Tokyo 16
Chicago 15
Jinan 14
London 14
San Mateo 14
The Dalles 14
Brooklyn 13
Changsha 13
Turku 13
Poplar 12
Brussels 11
Helsinki 11
Auburn Hills 10
Boston 10
Chennai 10
Mexico City 10
San Francisco 10
Jiaxing 9
Kunming 9
Meppel 9
Moscow 9
Norwalk 9
Toronto 9
Atlanta 8
Johannesburg 8
Ningbo 8
Philadelphia 8
Belo Horizonte 7
Denver 7
Zhengzhou 7
Amsterdam 6
Guangzhou 6
Lanzhou 6
Stockholm 6
Ankara 5
Des Moines 5
Hangzhou 5
Mountain View 5
Mumbai 5
Orange 5
Redmond 5
San Jose 5
Tampa 5
Bexley 4
Campinas 4
Fuzhou 4
Guarulhos 4
Haiphong 4
Manchester 4
Pune 4
Ribeirão Preto 4
Brasília 3
Charlotte 3
Curitiba 3
Dubai 3
Erbil 3
Guayaquil 3
Indiana 3
Totale 4.640
Nome #
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 200
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 197
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 186
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 184
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 178
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 174
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 174
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 173
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 172
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 172
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 170
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 169
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 166
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 164
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 161
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 160
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 157
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 156
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 152
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 151
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 146
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 145
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 144
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 140
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 140
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 139
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease 138
Expression and functionality of adenosine receptors in human blood cells 137
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 136
Expression and functional A3 adenosine receptors in human lymphocytes 134
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 132
Expression, pharmacological profile, and functional coupling of A(2B) receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [H-3]MRE 2029-F20 128
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 126
Effects of doxazosin and propranolol on A2A adenosine receptos of essential hypertensive patients 123
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 122
Aberrant A2A adenosine receptor function in peripheral blood cells of Huntington's disease patients and at risk mutation carriers. 118
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 114
Pharmacological and biochemical characterization of A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells. 113
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils. 112
null 106
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 104
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors 103
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. 99
null 90
null 87
Totale 6.803
Categoria #
all - tutte 28.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 554
Totale 28.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 75 7 59 6 57 67 24
2021/2022465 9 48 36 16 11 17 10 16 18 37 55 192
2022/2023587 47 69 18 75 128 66 32 45 59 2 28 18
2023/2024249 23 22 7 7 33 61 6 9 8 4 15 54
2024/20251.051 16 29 70 78 135 117 46 46 111 119 167 117
2025/20261.735 353 87 234 388 488 185 0 0 0 0 0 0
Totale 6.803